Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11137 - 11144 of 12140 results
Counterfeits, Trademark Infringement, and Contributory Liability: Your Vendors are Your Problem
June 18, 2013| Blog| Viewpoint
More About Trademark Surnames: The Borghese Dispute
June 17, 2013| Blog| Viewpoint
DOE Releases New Protocols to Determine Energy Efficiency Savings
June 17, 2013| Article| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on June 17, 2013
June 17, 2013| Blog| Viewpoint
Financial Innovation for Clean Energy Deployment: Congress Considers Expanding Master Limited Partnerships for Clean Energy
June 14, 2013| Article| Viewpoint
Solar PV Capacity Quickly Expands When States Provide the Right Incentives
June 14, 2013| Article| Viewpoint
SiNode Systems Takes Home the National Clean Energy Business Competition Prize
June 13, 2013| Blog| Viewpoint
Seventh Circuit Declines to Review Class Certification Order in Enormous Computer Privacy Class Action
June 13, 2013| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|